Groningen

• A phase I study investigating the local tolerability and pharmacokinetics of isoniazid (INH) inhalation by wet nebulization in patients with … Recruiting
  2024-517793-25-00 1 2026-03-30 Tuberculosis
• Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Previously Untreated, Unresectable, or Met … Recruiting
  2025-523224-45-00 10 2026-03-30 Untreated, Unresectable or Metastatic Colorectal Cancer
• Phase III Study of Rilvegostomig in Combination withBevacizumab with or without Tremelimumab as First-lineTreatment of Hepatocellular Carcin … Recruiting
  2024-518210-81-00 5 2026-03-18 Advanced Hepatocellular Carcinoma
• A Phase I, open-label, non-randomized study to assess the absorption, distribution, metabolism and excretion (ADME) and pharmacokinetics of … Recruiting
  2025-524172-29-00 3 2026-03-18 Healthy volunteers
• A study investigating the safety, absorption, and elimination of RO7795068, a new compound that may potentially be used in the treatment of … Recruiting
  2025-524856-73-00 3 2026-03-13 Not Applicable
• A study to see how RO7763505 works and how safe it is when given to healthy people and people with stable heart disease Recruiting
  2025-524693-42-00 1 2026-03-09 Stable Coronary Artery Disease (CAD)
• A Phase 2 study to assess the safety and efficacy of SUL-238 in patients with early, untreated Parkinson’s Disease Recruiting
  2025-524674-42-00 4 2026-03-05 Parkinson’s Disease
• A Phase I study to evaluate the Safety, Tolerability, and Pharmacokinetics of BAL2420 in Healthy Adult Subjects Recruiting
  2025-523108-59-00 1 2026-03-04 Severe infections caused by Gram-negative bacteria
• The PEARL trial: Prevention of hepatic Encephalopathy by administration of Rifaximin and Lactulose in patients with liver cirrhosis undergoi … Recruiting
  2024-512040-28-01 6 2026-03-01 Confirmed diagnosis of Alcoholic liver cirrhosis
• method VALIDation and evaluation of non-radioactive methods to measure Glomerular Filtration Rate Recruiting
  2023-509156-34-02 6 2026-02-17 Chronic Kidney Disease Kidney Failure
• A single and multiple ascending dose study of topical ladarixin ophthalmic solution in healthy volunteers Recruiting
  2025-524527-46-00 1 2026-02-16 Ocular inflammatory conditions
• A research study to look at the distribution and effects of coramitug on amyloid deposits in heart tissue using PET/CT imaging in people wit … Recruiting
  2024-519372-22-00 3 2026-02-12 transthyretin amyloid amyloidosis cardiomyopathy (ATTR-CM)
• A Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants Recruiting
  2025-524310-28-00 3 2026-02-02 Epilepsy, amotrophic lateral sclerosis, neuropathy
• Brivekimig for the treatment of moderate to severe hidradenitis suppurativa Recruiting
  2025-522333-61-00 4 2026-01-23 Hidradenitis suppurativa
• A Study of Amivantamab in Addition to Standard of Care Agents Compared with Standard of Care in Participants With Recurrent/Metastatic Head … Recruiting
  2025-521917-24-00 5 2026-01-21 Treatment-Naïve Recurrent/Metastatic Head and Neck Squamous Cell Carci
• A Single-Center, Double-Blind, Randomized, Placebo Controlled Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics, and P … Recruiting
  2025-523885-25-00 1 2026-01-21 Healthy Volunteers
• IMCISION: Towards organ preservation and cure via ultra-short immunotherapy in advanced oral cancer. The IMCISION II trial, an investigator … Recruiting
  2025-522500-24-00 5 2026-01-20 Head and Neck squamous cell carcinoma
• A Phase 3 Study of JNT-517 in Participants with Phenylketonuria Recruiting
  2024-519554-37-00 5 2026-01-16 Phenylketonuria
• Evaluating PD-1/PD-L1 in rectal cancer by quantitative fluorescence molecular endoscopy. Recruiting
  2023-507106-13-00 1 2026-01-12 Locally advanced rectal cancer
• A study to investigate the efficacy, safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation Recruiting
  2025-520518-79-00 4 2026-01-06 Atrial Fibrillation
• Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer Recruiting
  2025-521771-31-00 3 2026-01-05 Cervical Cancer
• A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic … Recruiting
  2025-522860-34-00 5 2025-12-16 Chronic lymphocytic leukemia (CLL)
• A clinical study of MK-1084 and other treatments for lung cancer (MK-1084-007) Recruiting
  2024-514500-14-00 5 2025-12-15 Participants with KRAS G12C-Mutant, Advanced or Metastatic Nonsquamous
• A 52-week study of rilzabrutinib efficacy and safety compared to placebo in adults diagnosed with IgG4-related disease Recruiting
  2025-521398-15-00 5 2025-12-04 Immune system diseases

Showing 121–144 of 679 trials